US Edition
FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures
The panel will weigh whether seven peptides, including BPC-157 and TB-500, can be routinely compounded after years of tighter FDA limits.
- On Wednesday, the Food and Drug Administration announced it will convene an outside panel of advisers in July to review whether compounding pharmacies can manufacture seven specific peptide injections.
- Health Secretary Robert F. Kennedy Jr. has repeatedly pledged to loosen restrictions on these unapproved therapies, which proponents market as aids for building muscle, healing injuries, or appearing younger.
- In 2023, federal regulators restricted 19 peptides, citing safety risks like cancer and organ damage, after an advisory panel determined they lacked sufficient human testing for safe compounding.
- On platforms like TikTok, overseas suppliers sell peptide varieties from China for as little as $5 a vial, a market the industry argues exists because of current U.S. regulatory restrictions.
- The upcoming panel will evaluate whether substances like BPC-157 and TB-500 should return to the list of routinely compounded drugs, despite ongoing regulatory concerns about their unproven safety.
24 Articles
24 Articles
FDA Eases Peptide Limits With Backing From RFK Jr.
Federal regulators are going to ease limits on a dozen substances favored by wellness influencers, Health Secretary Robert F. Kennedy Jr. said on April 15. Regulators will be removing 12 peptides from a list of substances that cannot be manufactured by compounding pharmacies, Kennedy wrote on X. The peptides include BPC-157 and Melanotan II. “Today, we took long-overdue action to restore science, accountability, and the rule of law,” Kennedy sai…
FDA to Weigh Easing Limits on Unproven Peptides Favored by RFK Jr.
(MedPage Today) -- The FDA will hold a meeting this summer to consider easing restrictions on more than a half-dozen peptide injections, a group of unapproved therapies that have become popular among wellness influencers, fitness gurus, and celebrities...
Coverage Details
Bias Distribution
- 45% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
